TNBC is a subtype of breast cancer observed in HBC and CMT that lacks the expression of three key receptors: the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ESR1 and breast carcinoma.